KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Shares Issued (2016 - 2025)

Charles River Laboratories International (CRL) has 16 years of Shares Issued data on record, last reported at $711000.0 in Q4 2025.

  • For Q4 2025, Shares Issued fell 7.42% year-over-year to $711000.0; the TTM value through Dec 2025 reached $714000.0, down 97.01%, while the annual FY2025 figure was $714000.0, 97.01% down from the prior year.
  • Shares Issued reached $711000.0 in Q4 2025 per CRL's latest filing, up from $2000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $21.5 million in Q1 2024 and bottomed at $1000.0 in Q2 2025.
  • Average Shares Issued over 5 years is $6.4 million, with a median of $3.9 million recorded in 2023.
  • Peak YoY movement for Shares Issued: surged 216.51% in 2022, then plummeted 99.88% in 2025.
  • A 5-year view of Shares Issued shows it stood at $2.3 million in 2021, then soared by 216.51% to $7.4 million in 2022, then fell by 19.74% to $5.9 million in 2023, then plummeted by 87.07% to $768000.0 in 2024, then decreased by 7.42% to $711000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $711000.0 in Q4 2025, $2000.0 in Q3 2025, and $1000.0 in Q2 2025.